Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine after total knee arthroplasty in patients with preoperative sleep disorder
ChiCTR2600133464Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in sleep disorder (2 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: Incidence of sleep disturbance on the first postoperative night. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
sleep disorder
Beyond the preview
Go deeper on ChiCTR2600133464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133464.